Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network. Br J Cancer. 2015;112(9):1575–84.

Article  PubMed  PubMed Central  Google Scholar 

Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443–59.

Article  PubMed  Google Scholar 

Villavicencio A, Solans M, Aunon-Sanz C, Roncero JM, Marcos-Gragera R. Population-based survival of lymphoid neoplasms: twenty years of epidemiological data in the Girona province, Spain. Cancer Epidemiol. 2020;69: 101841.

Article  PubMed  Google Scholar 

Mangone L, Penna D, Marinelli F, Roncaglia F, Bisceglia I, Merli F, et al. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020. Front Oncol. 2023;13:1182971.

Article  PubMed  PubMed Central  Google Scholar 

Lim RBT, Loy EY, Lim GH, Zheng H, Chow KY, Lim ST. Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: secular trends of a population-based cancer registry from 1998 to 2012. Int J Cancer. 2015;137(11):2674–87.

Article  PubMed  Google Scholar 

Bassig BA, Au WY, Mang O, Ngan R, Morton LM, Ip DK, et al. Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001–2010. Cancer Epidemiol. 2016;42:15–23.

Article  PubMed  Google Scholar 

Ko BS, Chen LJ, Huang HH, Wen YC, Liao CY, Chen HM, et al. Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002–2012. Cancer Med. 2018;7(11):5820–31.

Article  PubMed  PubMed Central  Google Scholar 

Touma E, Antoun L, Hallit S, Nasr F, Massoud M, El Othman R, et al. Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019. BMC Public Health. 2021;21(1):1820.

Article  PubMed  PubMed Central  Google Scholar 

Aladily TN, Khreisat W, Ashukhaibi O, Alkhatib SM, Annab H, Tarawneh MS, et al. The epidemiology of lymphoma in Jordan: a nationwide population study of 4189 cases according to World Health Organization classification system. Hematol Oncol Stem Cell Ther. 2021;14(4):336–42.

Article  PubMed  Google Scholar 

Muto R, Miyoshi H, Sato K, Furuta T, Muta H, Kawamoto K, et al. Epidemiology and secular trends of malignant lymphoma in Japan: analysis of 9426 cases according to the World Health Organization classification. Cancer Med. 2018;7(11):5843–58.

Article  PubMed  PubMed Central  Google Scholar 

Sim J, Takayama T, Cho J, Kim SJ, Kim WS, Ree HJ, et al. Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016: an observational study. Medicine (Baltim). 2019;98(45): e17641.

Article  Google Scholar 

Wang SS, Vose JM. Epidemiology and prognosis of T-cell lymphoma. In: T-cell lymphomas. Humana Press Inc.; 2013. p. 25–39. https://doi.org/10.1007/978-1-62703-170-7_2.

Chuang SS, Chen SW, Chang ST, Kuo YT. Lymphoma in Taiwan: review of 1347 neoplasms from a single institution according to the 2016 revision of the World Health Organization Classification. J Formos Med Assoc. 2017;116(8):620–5.

Article  PubMed  Google Scholar 

Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma. 2008;49(11):2099–107.

Article  PubMed  Google Scholar 

Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Cancer registry annual report. https://www.hpa.gov.tw/Pages/List.aspx?nodeid=269. Released Jan 2023.

Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER Research Limited-Field Data, 22 Registries, Nov 2022 Sub (2000–2020)-Linked To County Attributes-Time Dependent (1990–2021) Income/Rurality, 1969–2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission.

Surveillance Research Program, National Cancer Institute SEER*Stat software (seer.cancer.gov/seerstat) version 8.4.2.

Joinpoint Regression Program, Version 4.9.1.0. April, 2022; Statistical Research and Applications Branch, National Cancer Institute.

Chihara D, Fanale MA. Management of anaplastic large cell lymphoma. Hematol Oncol Clin N Am. 2017;31(2):209–22.

Article  Google Scholar 

Park S, Ko YH. Peripheral T cell lymphoma in Asia. Int J Hematol. 2014;99:227–39.

Article  PubMed  Google Scholar 

Adams SV, Newcomb PA, Shustov AR. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol. 2016;34(9):963–71.

Article  PubMed  PubMed Central  Google Scholar 

Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536–45.

Article  PubMed  Google Scholar 

Crawford DH. Biology and disease associations of Epstein–Barr virus. Philos Trans R Soc Lond B Biol Sci. 2001;356(1408):461–73.

Article  PubMed  PubMed Central  Google Scholar 

Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.

Article  PubMed  Google Scholar 

Su ZY, Siak PY, Leong CO, Cheah SC. The role of Epstein–Barr virus in nasopharyngeal carcinoma. Front Microbiol. 2023;14:1116143.

Article  PubMed  PubMed Central  Google Scholar 

de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, et al. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. Haematologica. 2015;100(9):e361–4.

Article  PubMed  PubMed Central  Google Scholar 

Yabe M, Yabe M, Dogan A, Horwitz SM, Moskowitz AJ. Angioimmunoblastic T-cell lymphoma. Cancer Treat Res. 2019;176:99–126.

Article  PubMed  Google Scholar